Roche Closes 454 But Company Not Out of Next-Gen Yet

Roche Closes 454 But Company Not Out of Next-Gen Yet

In Kalorama’s report, " Next Generation Sequencing Trends ," our survey discovered that while 75% of labs had an Illumina sequencer, less than a third had a Roche brand sequencer and it was not generally part of our surveyed labs’ purchasing plans. Roche’s recent move confirms our findings and admists market reality.

This month, Roche announced the closing its wholly-owned subsidiary 454 Life Sciences and laying off the company’s 130 employees. They will keep making sequencers, however, throug...

  • by bcarlson@marketresearch.com
  • October 17 2013


With Fingers Crossed, Biosimilars Market Expected to Grow

With Fingers Crossed, Biosimilars Market Expected to Grow

It’s not the first prediction that has been made about the market for generic forms of biopharmaceutical drugs, but according to Kalorama Information a multi-billion dollar market for biosimilars will arrive in the next five years. Kalorama Information’s new report, The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon alpha, Monoclonal Antibodies, Others), predicts a market of nearly $5 billion dollars. There’s a reason. Biosimilar development is in almost everyone’s interest -...


Hematology Industry Mapping and Its Boundaries

Hematology Industry Mapping and Its Boundaries

Laboratory hematology is largely synonymous with its leading vendors such as Beckman Coulter and Sysmex. High order volumes among such vendors are ensured through established relationships with premium clients such as care networks, other large healthcare institutions, clinical laboratories, and reference labs. The profile of companies such as Beckman Coulter and Abbott Diagnostics is also higher due to the breadth of their product offering, particularly within the core lab - clinical chemistry,...

  • by esalazar@marketresearch.com
  • October 11 2013


Foodborne Pathogens Don’t Pause during Government Shutdown

Foodborne Pathogens Don’t Pause during Government Shutdown

The current government shutdown has unexpectedly brought food safety to the fore once again in the United States. This week, the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) issued an alert for Salmonella in Foster Farms chicken. Per the FSIS’s contingency plans, several activities remain exempt and continue through the shutdown, including the inspection of poultry and poultry products.

The critical nature of food safety - both of domestic and imported food...

  • by bcarlson@marketresearch.com
  • October 9 2013


Opportunity in Brazil IVD Market

Opportunity in Brazil IVD Market

Saying Brazil is large is an understatement. The entire European Union could fit comfortable within the geography of Brazil. The only countries in the world that are larger are Russia, Canada, the People’s Republic of China, and the United States. Its economy is growing and government spending, including healthcare, has been enlarged in recent years. Its population of nearly 200 million people demand services, including preventive testing. IVD is one of the many markets growing in the country. B...

  • by bcarlson@marketresearch.com
  • October 3 2013


Don’t Count Out Capillary Systems Yet

Don’t Count Out Capillary Systems Yet

Despite the adoption of next-generation DNA sequencing (NGS) systems, Kalorama Information says that older capillary DNA sequencing systems remain in labs and are used consistently. More than one out of every four sequencers owned by labs surveyed is still a Sanger or capillary type system, and almost all are made by Life Technologies/Applied Biosystems. And those labs that own them are still employing them at a fairly stable rate. The findings were made in a new Kalorama Information report, “Ne...

  • by bcarlson@marketresearch.com
  • October 1 2013


Cloud Computing in Healthcare A Nearly 4 Billion Dollar Market

Cloud Computing in Healthcare A Nearly 4 Billion Dollar Market

Cloud computing systems, off-site servers that can store information accessible to healthcare organization employees at a different location, are among the healthcare IT products most in demand, according to Kalorama Information. The global market for cloud computing in healthcare is estimated to reach $3.9 billion for 2013, representing 21.1% growth over the 2012 year. The push to adopt a higher level of IT in healthcare, growing government mandates, limitations in digital storage, staffing sho...

  • by admin1
  • September 7 2013


Healthcare Reform Should Help IVD Industry, At Least Slightly

On the whole, Patient Protection and Affordable Care Act is expected to benefit the IVD and clinical lab test industry slightly, according to Kalorama Information. Sales are expected to rise an extra 1.3% more per year, in the next five years, than would have otherwise been seen without the law, according to a recent report from the firm. This finding was made in a recently published Kalorama Information report, The Impact of Healthcare Reform (PPACA) On the U.S. IVD Market.

The healthcare mar...

  • by admin1
  • September 7 2013


AACC Meeting Provides Industry Glance

The very size of the American Association of Clinical Chemistry is a testament to the growth of the IVD industry that Kalorama has covered for decades. This year’s AACC in Houston, TX did not disappoint. 650 companies exhibited, 100 of them were new.

Key areas of interest were emerging markets for IVD, Vitamin D’s continued role in the face of controversy, and the recent Supreme Court ruling that isolated human DNA cannot be patented. AACC hosted a panel featuring ACLU Lead Counsel Sandra Park...

  • by admin1
  • September 7 2013


Proof of RPM Benefit Emerges

Proof of RPM Benefit Emerges

The proof of the pudding is in the eating, or so the saying goes. For insurance companies and governments, they will reimburse if the product can show effectiveness. As detailed in our report on Advanced Remote Patient Monitoring (http://www.kaloramainformation.com/Advanced-Remote-Patient-7450566/) These developments will drive implementation of new systems.

Numerous studies in the United States and Europe have proven the cost benefits of remote patient monitoring (RPM), despite initial costs ...